Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…
Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Jan 15 (Reuters) – The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for…
Johnson & Johnson announces deal to cut drug prices, new Pennsylvania manufacturing site | Berks Regional News
NEW BRUNSWICK, Nj. – Johnson & Johnson is the latest U.S. drugmaker to announce a deal with the…
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…